Cargando…
Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms
BACKGROUND: Developing prediction tools for immunotherapy approaches is a clinically important and rapidly emerging field. The routinely used prediction biomarker is inaccurate and may not adequately utilize large amounts of medical data. Machine learning is a promising way to predict the benefit of...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552174/ https://www.ncbi.nlm.nih.gov/pubmed/36238300 http://dx.doi.org/10.3389/fimmu.2022.989275 |